Aura Biosciences
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -274 | 600 | -300 | -300 |
EBITDA | -34,592 | -26,965 | -27,626 | -26,671 |
EBIT | -34,866 | -27,237 | -27,906 | -26,971 |
Net Income | -33,685 | -25,559 | -26,130 | -27,019 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -29,995 | -20,645 | -20,189 | -20,813 |
Cash | 84,793 | 59,515 | 47,553 | 107,367 |
Basic Shares | 67,447 | 60,337 | 65,936 | 58,015 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,223 | -1,295 | -1,177 | |
EBITDA | -111,662 | -94,893 | -83,696 | -59,118 |
EBIT | -112,791 | -96,116 | -84,991 | -60,295 |
Net Income | -106,191 | -86,919 | -76,408 | -58,763 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -26,841 | |||
Free Cash Flow | -85,189 | -81,058 | -64,556 | -55,695 |
Cash | 59,515 | 31,693 | 41,063 | 121,582 |
Basic Shares | 60,337 | 49,650 | 39,620 | 29,937 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.50 |
2025-12-31 | -$0.37 |
2025-09-30 | -$0.40 |
2025-06-30 | -$0.47 |